BiotechTube
Home/Lomond Therapeutics/Amy Burd
AB

Amy Burd

CSO

Lomond Therapeutics

Roles

CSOatLomond Therapeutics
CSOatEilean Therapeutics

Therapeutic Areas

OncologyHematology

Lomond Therapeutics Pipeline

DrugIndicationPhase
lomonitinibAcute Myeloid Leukemia (AML)IND-Enabling
lonitoclaxChronic Lymphocytic Leukemia (CLL)Phase 1
Menin InhibitorAcute Myeloid Leukemia (AML)Discovery

Leadership Team at Lomond Therapeutics

ID
Iain Dukes
CEO
NS
Nikolay Savchuk
COO
BL
Brian Ledwith
Chief Development Officer
FP
Fraser Pickersgill
Head CMC
JB
John Byrd
Interim Chief Medical Officer
View full Lomond Therapeutics profile